Narrow search
Showing 1 - 10 of 1,437
Cover Image
Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A User's Guide
Lancsar, Emily; Louviere, Jordan - In: PharmacoEconomics 26 (2008) 8, pp. 661-677
Discrete choice experiments (DCEs) are regularly used in health economics to elicit preferences for healthcare products and programmes. There is growing recognition that DCEs can provide more than information on preferences and, in particular, they have the potential to contribute more directly...
Persistent link: https://www.econbiz.de/10005404768
Cover Image
The Authors' Reply
Green, Colin; Picot, Joanna; Loveman, Emma; Takeda, Andrea - In: PharmacoEconomics 24 (2006) 6, pp. 625-626
Persistent link: https://www.econbiz.de/10005404769
Cover Image
Cost-Effectiveness Analyses of Natalizumab (Tysabri(R)) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK
Gani, Ray; Giovannoni, Gavin; Bates, David; Kemball, Belinda - In: PharmacoEconomics 26 (2008) 7, pp. 617-627
Background: Natalizumab (Tysabri(R)) is a new disease-modifying therapy that has been shown to be clinically effective in patients with relapsing-remitting multiple sclerosis (RRMS) and has been licensed for use in patients with highly active RRMS (HARRMS). These patients are those who...
Persistent link: https://www.econbiz.de/10005404771
Cover Image
Transferability of Economic Evaluation Results
Antonanzas, Fernando - In: PharmacoEconomics 22 (2004) 13, pp. 827-827
Persistent link: https://www.econbiz.de/10005404772
Cover Image
Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS
Rachlis, Anita; Smaill, Fiona; Walker, Valery; … - In: PharmacoEconomics 16 (1999) 1, pp. 71-84
Objective: To evaluate the cost effectiveness of a new product, oral ganciclovir, in comparison to a current therapy … retinitis progressed. Safety and efficacy data were derived from the trial. A panel of Canadian infectious disease physicians … and family physicians estimated the following in relation to IV ganciclovir treatment for CMV retinitis and related …
Persistent link: https://www.econbiz.de/10005404773
Cover Image
The Cost of HIV Treatment and Care: A Global Review
Beck, Eduard J.; Miners, Alec H.; Tolley, Keith - In: PharmacoEconomics 19 (2001) 1, pp. 13-39
hospital costs increased significantly (p = 0.003) over the 3 periods analysed (before 1987, 1987 to 1995, and 1996 and beyond …-specific Gross Domestic Product Purchasing Power Parity converters. A summary of hospital cost estimates over time and by region …
Persistent link: https://www.econbiz.de/10005404774
Cover Image
Review of Quality-of-Life Evaluations in Patients with Angina Pectoris
Gandjour, Afschin; Lauterbach, Karl W. - In: PharmacoEconomics 16 (1999) 2, pp. 141-152
. A comparison of NHP scores with those of the healthy population revealed that patients with angina particularly seem to …
Persistent link: https://www.econbiz.de/10005404775
Cover Image
Discrete Choice Experiment to Derive Willingness To Pay for Methyl Aminolevulinate Photodynamic Therapy Versus Simple Excision Surgery in Basal Cell Carcinoma
Weston, Adele; FitzGerald, Patrick - In: PharmacoEconomics 22 (2004) 18, pp. 1195-1208
Objectives: This study aimed to determine willingness to pay (WTP) and preference for methyl aminolevulinate (MAL) photodynamic therapy compared with simple surgical excision for basal cell carcinoma (BCC). The relative preferences for individual features of the therapy were also determined....
Persistent link: https://www.econbiz.de/10005404776
Cover Image
Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study
Knapp, Martin; Windmeijer, Frank; Brown, Jacqueline; … - In: PharmacoEconomics 26 (2008) 4, pp. 341-358
analyses showed that 98% of the replications fell below a Lstg 30_000 per QALY gained threshold for the comparison with oral … typical antipsychotics, and 79% of replications for the comparison with depot preparations. Conclusions: Among SOHO patients … probability of being the most cost-effective treatment compared with other antipsychotic treatments. However, comparison of …
Persistent link: https://www.econbiz.de/10005404777
Cover Image
Pharmacoeconomic Analysis of Bemiparin and Enoxaparin as Prophylaxis for Venous Thromboembolism in Total Knee Replacement Surgery
Honorato, Jesus; Gomez-Outes, Antonio; Navarro-Quilis, … - In: PharmacoEconomics 22 (2004) 13, pp. 885-894
replacement (TKR) surgery, considering both in-hospital and post-discharge outcomes and costs during 6 weeks of postoperative …
Persistent link: https://www.econbiz.de/10005404778